Divalproex Sodium
Product Images NDC 53808-0940

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 53808-0940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 250mg (250mg Unichem)

This text contains some medical information and details about a prescription drug called Divalproex Sodium, available in 250mg tablets. The lot number and expiration date of a specific batch are also provided, as well as the fact that it is only available with a prescription. The package was handled by DOH Central Pharmacy in Florida. The last line appears to be a garbled mix of characters that cannot be interpreted.*

FDA Label Image

Structure Of Divalproex Sodium (Divalproextablets Figure 01)

FDA Label Image

Percentages Of Patients Achieving = 30 % Reduction In Symptom Score From Baseline (Divalproextablets Figure 02)

FDA Label Image

Mean 4 (week migraine rates)

FDA Label Image

Curve For An Effective Treatment In Adjunctive Therapy Study (Divalproextablets Figure 04)

FDA Label Image

Curve For An Effective Treatment In Monotherapy Study (Divalproextablets Figure 05)

This is a table displaying the reduction in CPS (Central Pain Syndrome) rate for high and low dose treatments. The table shows the percentage of patients for whom there was improvement, no change or worsening of CPS symptoms. There is no additional context provided.*

FDA Label Image

Company Logo (Divalproextablets Figure 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.